Vtesse's Acquisition

Vtesse was acquired by Sucampo Pharmaceuticals on April 03, 2017.

Vtesse is a rare disease company dedicated to developing drugs for patients suffering from underserved diseases. Vtesse closely collaborates with National Institutes of Health (NIH), parents, patient …

Articles about Vtesse's Acquisition: